Jump to content

Semustine: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m ChEBI ID added to box identifiers
CheMoBot (talk | contribs)
Updating {{drugbox}} (changes to verified and watched fields - updated 'ChEBI_Ref', 'Verifiedfields') per Chem/Drugbox validation (report errors or bugs)
Line 1: Line 1:
{{globalize|date=May 2012}}
{{globalize|date=May 2012}}
{{Drugbox
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| Watchedfields = changed
| verifiedrevid = 443222760
| verifiedrevid = 443222760
Line 37: Line 38:
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D05822
| KEGG = D05822
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 6863
| ChEBI = 6863



Revision as of 22:41, 7 September 2013

Semustine
Clinical data
ATC code
Identifiers
  • N-(2-Chloroethyl)-N'-(4-methylcyclohexyl)-N-nitrosourea
CAS Number
PubChem CID
UNII
KEGG
ChEBI
CompTox Dashboard (EPA)
ECHA InfoCard100.162.271 Edit this at Wikidata
Chemical and physical data
FormulaC10H18ClN3O2
Molar mass247.72 g/mol g·mol−1
 ☒NcheckY (what is this?)  (verify)

Semustine is a drug used in chemotherapy.[1] It is structurally similar to lomustine, being distinguished from it only by an additional methyl group. It has been taken off the drug market for investigation of its cancerous effects, rated as IARC Group 1 carcinogen or a known carcinogen.[citation needed]

References

  1. ^ PMID 1548520